IP Library Granted Patent US 8,851,077
Granted Patent B2
US 8,851,077 · App. 13/898,196 · Granted Oct 7, 2014

Methods and apparatus for occlusion of body lumens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,851,077
App. No.
13/898,196
Granted
Oct 7, 2014
Kind
B2
Abstract

The invention describes methods and apparatus for creating permanent occlusion of body lumens such as the fallopian tubes. The methods and apparatus use non-surgical approaches to deliver permanent implants which create acute occlusion of desired body lumens which resolve to permanent occlusions of the lumens.

Claims (30)

1. An implantable device for occluding a body lumen, comprising:

an elongate body comprising proximal and distal tissue engaging elements that are positionable inside a body lumen proximate to a desired occlusion site, the proximal and distal tissue engaging elements each being expandable and each comprising at least one tissue penetrating feature configured to engage wall tissue of the body lumen upon expansion, wherein one of the proximal and distal tissue engaging elements is independently rotatable relative to the other, and

wherein one of proximal and distal tissue engaging elements, when expanded to engage wall tissue of the body lumen and thereafter rotated relative to the body lumen, is operative to twist the lumen wall tissue to thereby form an occlusion of the body lumen.

2. The device of claim 1 , wherein the proximal and distal tissue engaging elements, when expanded, are further operative to be drawn together to fold wall tissue of the body lumen.

3. The device of claim 1 , wherein the elongate body further comprises a rod.

4. The device of claim 1 , at least one of the proximal and distal tissue engaging elements comprising an anchoring member that expands radially to form a tip that engages wall tissue of the body lumen.

5. The device of claim 1 , wherein the proximal and distal tissue engaging elements each comprises a self-expanding structure.

6. The device of claim 1 , wherein the proximal and distal tissue engaging elements each comprises a multi-planar structure.

7. A method of using an implantable device to create a permanent occlusion at a desired occlusion site in a fallopian tube, the method comprising:

inserting a device into the fallopian tube, such that a first tissue engaging element of the device is located distal of the desired occlusion site and a second tissue engaging element of the device is located proximal to the desired occlusion site;

actuating the device so as to rotate one of the first and second tissue engaging elements relative to the other to thereby reduce an open area of the fallopian tube located between the first and second tissue engaging elements;

decoupling the implantable device from a delivery system; and

withdrawing the delivery system, leaving the implantable device in the fallopian tube.

8. The method of claim 7 , wherein rotating the first tissue engaging element relative to the second tissue engaging element twists a circumferential wall portion of the fallopian tube located between the first and second tissue engaging elements.

9. The method of claim 8 , further comprising locking the first element relative to the second element after the wall portion is twisted to thereby maintain the twisted wall portion.

10. The method of claim 7 , further comprising engaging wall tissue of fallopian tube with each of the first and second tissue engaging elements, wherein actuating the device comprises moving the first element towards the second element to thereby form a fold in the fallopian tube wall tissue.

11. The method of claim 7 , further comprising imaging the occlusion site after actuating the device and before decoupling the implantable device from the delivery system.

12. The method of claim 7 , wherein the first and second tissue engaging elements are expanded when actuated.

13. An implantable device for occluding a body lumen, comprising:

a mechanism configured to be placed within a body lumen and to draw together and twist a circumferential wall portion of the body lumen with sufficient force such that an open cross-sectional area of said body lumen proximate the twisted circumferential wall portion is substantially reduced to thereby occlude the body lumen,

the mechanism including a first element and a second element, wherein one of the first and second elements is independently rotatable relative to other one,

at least one of the first and second elements comprising a tissue penetrating feature configured to engage wall tissue of the body lumen and to maintain the wall portion of the body lumen in a twisted configuration to allow tissue of the twisted wall portion on opposing lumen walls to fuse together through healing over time.

14. The device of claim 13 , wherein the mechanism comprises a material that causes a local reaction in the twisted tissue to thereby promote the healing over time.

15. The device of claim 13 , wherein each of the first and second elements comprises at least one tissue penetrating feature configured to penetrate and engage wall tissue of the body lumen.

16. A method of using an implantable device to create a permanent occlusion at a desired occlusion site in a body lumen, the method comprising:

inserting a device into the body lumen, such that a first tissue engaging element of the device is located distal of the desired occlusion site and a second tissue engaging element of the device is located proximal to the desired occlusion site;

actuating the device so as to rotate one of the first and second tissue engaging elements relative to the other to thereby reduce an open area of the body lumen located between the first and second tissue engaging elements;

decoupling the implantable device from a delivery system; and

withdrawing the delivery system, leaving the implantable device in the body lumen,

wherein the first and second tissue engaging elements each comprise at least one tissue penetrating feature configured to engage wall tissue of the body lumen.

Assignments (4)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE R/F 030755 0031 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036127/0538 →
SECURITY AGREEMENT Recorded Jul 9, 2013
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE, INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 030755/0031 →